BACKGROUND AND AIMS: Hydatid disease is still a major health problem in sheep-raising areas. Surgery remains the basic treatment for liver hydatid cyst (LHC). However, recurrences can occur after all therapies. Surgery for recurrence of LHC becomes technically more difficult with higher rate of morbidity and mortality. The aim of this study was to determine perfective factors associated to hepatic recurrence after LHC surgery and to propose and discuss postoperative follow-up schedules. METHODS: It is a retrospective cohort study of 672 patients with LHC treated at the surgery department "A" at Ibn Sina University Hospital, Rabat, Morocco, from January 1990 to December 2004. Recurrence rates have been analyzed by the Kaplan-Meier method for patients undergoing surgery. RESULTS: Fifty-six patients (8.5%) had LHC recurrence after surgery. There were 34 females (60.7%) and 22 males (39.3%). Median duration of recurrence's diagnosis was 24 months (interquartile range: 10-48 months). Recurrence's risk was 2.3% +/- 0.6% at 1 year and 9.1% +/- 1.3% at the 10th year. The history of LHC (hazard ratio, 2; 95% confidential interval, 1.13-3.59) and three cysts or more (hazard ratio, 3.8; 95% confidential interval, 2.07-6.98) was an independent risk factor for recurrence. CONCLUSION: We think that the surgeon's practice and experience are the most important to success the surgical treatment. It prevents complications and recurrences.
BACKGROUND AND AIMS: Hydatid disease is still a major health problem in sheep-raising areas. Surgery remains the basic treatment for liver hydatid cyst (LHC). However, recurrences can occur after all therapies. Surgery for recurrence of LHC becomes technically more difficult with higher rate of morbidity and mortality. The aim of this study was to determine perfective factors associated to hepatic recurrence after LHC surgery and to propose and discuss postoperative follow-up schedules. METHODS: It is a retrospective cohort study of 672 patients with LHC treated at the surgery department "A" at Ibn Sina University Hospital, Rabat, Morocco, from January 1990 to December 2004. Recurrence rates have been analyzed by the Kaplan-Meier method for patients undergoing surgery. RESULTS: Fifty-six patients (8.5%) had LHC recurrence after surgery. There were 34 females (60.7%) and 22 males (39.3%). Median duration of recurrence's diagnosis was 24 months (interquartile range: 10-48 months). Recurrence's risk was 2.3% +/- 0.6% at 1 year and 9.1% +/- 1.3% at the 10th year. The history of LHC (hazard ratio, 2; 95% confidential interval, 1.13-3.59) and three cysts or more (hazard ratio, 3.8; 95% confidential interval, 2.07-6.98) was an independent risk factor for recurrence. CONCLUSION: We think that the surgeon's practice and experience are the most important to success the surgical treatment. It prevents complications and recurrences.
Authors: Michael C Safioleas; Evangelos P Misiakos; Maria Kouvaraki; Michael K Stamatakos; Christine P Manti; Evangelos S Felekouras Journal: Arch Surg Date: 2006-11
Authors: Sajad Hussain Arif; Nazir Ahmad Wani; Showkat Ahmad Zargar; Mehmood Ahmad Wani; Rehana Tabassum; Zahoor Hussain; Ajaz Ahmad Baba; Riyaz Ahmad Lone Journal: Int J Surg Date: 2008-08-16 Impact factor: 6.071
Authors: Seckin Akkucuk; Akin Aydogan; Mustafa Ugur; Ibrahim Yetim; Ramazan Davran; Cem Oruc; Erol Kilic; Muhyittin Temiz Journal: Int J Clin Exp Med Date: 2014-08-15
Authors: Mohammad Al-Saeedi; Ali Ramouz; Elias Khajeh; Ahmad El Rafidi; Omid Ghamarnejad; Saeed Shafiei; Sadeq Ali-Hasan-Al-Saegh; Pascal Probst; Marija Stojkovic; Tim Frederik Weber; Katrin Hoffmann; Arianeb Mehrabi Journal: PLoS Negl Trop Dis Date: 2021-05-12
Authors: Virginia Velasco-Tirado; Ángela Romero-Alegría; Moncef Belhassen-García; Montserrat Alonso-Sardón; Carmen Esteban-Velasco; Amparo López-Bernús; Adela Carpio-Perez; Marcelo Fernando Jimenez López; Juan Luis Muñoz Bellido; Antonio Muro; Miguel Cordero-Sanchez; Javier Pardo-Lledias; Luis Muñoz-Bellvis Journal: BMC Infect Dis Date: 2017-06-27 Impact factor: 3.090